CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 94 filers reported holding CTI BIOPHARMA CORP in Q4 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $464,000 | -9.9% | 1,137,955 | -17.3% | 0.00% | – |
Q3 2016 | $515,000 | +1.6% | 1,375,394 | -7.7% | 0.00% | – |
Q2 2016 | $507,000 | +692.2% | 1,490,528 | +1137.2% | 0.00% | – |
Q1 2016 | $64,000 | -83.9% | 120,480 | -62.8% | 0.00% | – |
Q4 2015 | $398,000 | +0.5% | 323,509 | +19.1% | 0.00% | – |
Q3 2015 | $396,000 | -59.6% | 271,582 | -45.9% | 0.00% | – |
Q2 2015 | $979,000 | +53.4% | 502,188 | +42.4% | 0.00% | – |
Q1 2015 | $638,000 | -54.0% | 352,700 | -39.9% | 0.00% | – |
Q4 2014 | $1,386,000 | +26.6% | 587,078 | +29.7% | 0.00% | – |
Q3 2014 | $1,095,000 | -3.1% | 452,470 | +12.5% | 0.00% | – |
Q2 2014 | $1,130,000 | – | 402,051 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|